Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NeuroInfo i Stockholm AB
AB
Active
Org 5565909669
Tomtebogatan 26 A, 113 38
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2000
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NeuroInfo i Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
1M
2026
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
0M
2026
Income statement
SEK thousands
Item
2022
2023
2024
2025
2026
Revenue
164
246
490
308
514
Staff expenses
−23
−133
−22
−40
−37
EBITDA
−16
−151
184
33
213
Depreciation & amort.
—
—
—
—
—
EBIT
−16
−151
184
33
213
Net financials
182
75
12
19
31
Profit before tax
166
74
196
52
245
Tax
−14
−15
−41
−11
−54
Net profit
52
59
155
41
191
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
2026
Total assets
1 751
1 467
1 347
1 181
1 176
Equity
1 154
1 025
891
728
710
Long-term debt
—
—
—
—
—
Short-term debt
46
41
55
51
66
Total debt
46
41
55
51
66
Financial ratios
5-year trend
EBITDA margin
41.5%
This company
15.8%
Market median
+163% vs market
2022
2026
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
2022
2026
Return on equity
26.9%
This company
18.4%
Market median
+46% vs market
2022
2026
Net profit margin
37.2%
This company
8.1%
Market median
+359% vs market
2022
2026
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
2022
2026
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
2022
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-05-01 – 2026-04-30
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
More on NeuroInfo i Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
